Gold and Silver Prices Decline as Precious Metals Face Continued Selling Pressure Reddit Shares Slide Nearly 6 After Meta Unveils Forum App for Facebook Groups AIPowered RealTime Feedback Reshaping Customer Experience Strategies Costcos Gas Stations Gain Traction as Soaring Fuel Prices Drive Frugal Shoppers SpaceX IPO Filing Highlights Starlink as Key Profit Engine Ahead of Potential Nasdaq Listing Trump Trade Czar Signals Tariffs on Canada Mexico Will Stay Despite USMCA RARE Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues DLR Q1 2026 Earnings Slight EPS Beat Amid Steady Data Center Demand Highwoods Properties Inc HIW Q1 2026 Earnings Significant EPS Surprise Driven by Strong Operational Performance AMTD IDEA Group Q4 2020 Earnings Strong EPS Beat Amid Revenue Disclosure Gap NMRA Q1 2026 Earnings NarrowerThanExpected Loss and Steady Progress in CNS Pipeline Republic Services RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency ING Group ING Slips Slightly Amid Mixed Sector Sentiment Key Levels in Focus DexCom DXCM Slips 236 as Selling Pressure Tests Key Support Zone GreenPower Motor Co GP Struggles Near Support at 100 as Shares Edge Lower Zions Bancorporation ZION Edges Higher as Regional Banking Sentiment Stabilizes XP Inc XP Shares Slide Over 6 Support Levels Under Pressure Indonesian Commodity Exporters Raise Concerns Over State Monopoly Push Golden Entertainment GDEN Q4 2025 Earnings Steep Earnings Miss Amid Operational Challenges Heartland Express HTLD Edges Higher as Stock Holds Above Key Support Levels MRCY Q1 2026 Earnings Massive EPS Surprise of 284 Drives Stock Higher TWOD Q1 2026 Earnings Strong EPS Beat Driven by Favorable Interest Rate Environment Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue ELTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CDLX Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline Revenue Remains Under Wraps ACTU Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress